Stephen A. Whelan: How SARS-CoV-2 Infection Reprograms Tryptophan Metabolism
Stephen A. Whelan, Founder at Tamino Bio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“Congratulations to Vipul Chitalia, Saravanan Subramaniam, Marc Napoleon, and the entire team on this publication.
In this collaborative study, the authors investigated how SARS-CoV-2 infection reprograms tryptophan metabolism and contributes to a prothrombotic state through activation of the kynurenine–AHR–tissue factor signaling axis.
Key findings included:
- SARS-CoV-2 infection increased kynurenine pathway metabolites in both mouse models and human patients.
- Elevated kynurenine signaling was associated with activation of procoagulant pathways in endothelial cells.
- Pharmacologic inhibition of IDO-1 or AHR reduced tissue factor induction, highlighting a potentially targetable pathway linking metabolism, inflammation, and thrombosis.
- The study identified the kynurenine–AHR–TF axis as a potential diagnostic and therapeutic target for COVID-19-associated thrombosis.
I was pleased to contribute metabolomics analyses to this work using the metabolomics platform I built and operated at Boston University’s Chemical Instrumentation Center (CIC) between 2018–2021.
Studies like this demonstrate the value of integrating metabolomics, proteomics, and systems biology approaches to better understand disease mechanisms and identify new diagnostic and therapeutic opportunities.”
Title: Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2
Authors: Saravanan Subramaniam, Marc Arthur Napoleon, Saran Lotfollahzadeh, Mohamed Hassan Kamal, Helena Kurniawan, Christina Francis, Murad Elsadawi, David Jasen Wu Wong, Devin Kenney, Florian Douam, Markus Bosmann, Stephen A. Whelan, Howard Cabral, Eric J. Burks, Grace Zhao, Vijaya B. Kolachalama, Katya Ravid, Vipul C. Chitalia

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI